Recent advances in the selective semi-hydrogenation of alkyne to ( E )-olefins
Chemical Communications · 2024 · 60 (12) · 1517-1533
DOI: 10.1039/d3cc05395d ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2024. Verfasst von Motahar Sk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Laboratory of Catalysis and Organic Synthesis Indian Institute of Technology Roorkee, Roorkee-247667, Uttarakhand, India. de…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
This article highlights the recent advances on newer technologies and important methodologies directed to ( E )-olefins from alkynes.
Autor:innen und Institutionen
- Department of Chemistry, Laboratory of Catalysis and Organic Synthesis Indian Institute of Technology Roorkee, Roorkee-247667, Uttarakhand, India. debasis.banerjee@cy.iitr.ac.in.
Förderung
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
Zitieren
APA
Sk, M., Haldar, S., Bera, S., & Banerjee, D. (2024). Recent advances in the selective semi-hydrogenation of alkyne to ( E )-olefins. Chemical Communications, 60(12), 1517-1533. https://doi.org/10.1039/d3cc05395d
Vancouver
Sk M, Haldar S, Bera S, Banerjee D. Recent advances in the selective semi-hydrogenation of alkyne to ( E )-olefins. Chemical Communications. 2024;60(12):1517-1533. doi:10.1039/d3cc05395d
BibTeX
@article{Sk2024,
author = {Sk, Motahar and Haldar, Shuvojit and Bera, Sourajit and Banerjee, Debasis},
title = {Recent advances in the selective semi-hydrogenation of alkyne to ( E )-olefins},
journal = {Chemical Communications},
year = {2024},
volume = {60},
number = {12},
pages = {1517--1533},
doi = {10.1039/d3cc05395d}
}
EUVIMED